Review identifies key strategies to prevent recurrent hepatic encephalopathy episodes

For the roughly one in five Americans with cirrhosis who face hepatic encephalopathy, a failing liver becomes a doorway through which toxins reach the brain, quietly dismantling cognition, independence, and livelihood. A new review of the medical literature offers a structured path through this landscape — one built on education, nutritional support, and a pharmacological ladder anchored by lactulose and rifaximin — at a moment when the human and economic toll has grown too large to defer. The stakes are not merely clinical: nearly half of patients return to the hospital within a year, caregiv